US Capital Global to Advise MaxGevity on Multi-Million-Dollar Capital Formation for Rapid Expansion
US Capital Global has been appointed as the lead advisor to MaxGevity, Inc., a pioneer in canine wellness with scientifically-advanced treats, supplements, and extensive expansion plans.
US Capital Global is pleased to announce that MaxGevity, Inc. (“MaxGevity” or the “Company”) has engaged our group as their strategic lead advisor for a potential multi-million-dollar financing initiative. MaxGevity is a trailblazer in canine wellness, offering award-winning treats and supplements that address critical health challenges in pets through innovative, science-based solutions.
With global headquarters in San Francisco and principal offices in Dallas, Philadelphia, Miami, New York, London, and Dubai, US Capital Global is a full-service global private financial group with an established track record in corporate finance, asset management, and capital formation services. All private placements, securities, and other related services are offered by the group’s FINRA-member, SEC-registered broker-dealer affiliate, US Capital Global Securities LLC.
Based in Santa Clara, California, MaxGevity is leading the canine wellness evolution with its award-winning pet treats and supplements. The Company is quickly becoming recognized as the “new authority in canine wellness” by industry giants and customers alike. MaxGevity addresses long-standing challenges in the pet food industry with its innovative proprietary and award winning formulas HTPA Prebiotic Advantage and HT20+ Symbiotic Advantage.
“At MaxGevity, we’re excited about our journey and the significant milestones we’ve achieved in canine wellness,” said Bob Welch, CEO of the Company. “With our strategic plans for expansion into global markets, including the UK and Canada, and our ongoing development of new and exciting innovative products with functional health benefits, we are committed to revolutionizing pet health and setting new standards in the industry.”
Lisa Terk, Senior Vice President at US Capital Global, expressed her enthusiasm for supporting MaxGevity, stating, “My client addresses an area of consumer retail pet products that is very close to our hearts, setting a new standard in optimal canine wellness with their groundbreaking, nutritional supplements and treats that will support your pet from puppyhood into their senior years. MaxGevity’s commitment to addressing critical health challenges and plans for future global expansion reflects a visionary approach to pet health. We are very excited to support MaxGevity in their mission to transform the industry and improve the lives of dogs worldwide.”
About MaxGevity, Inc.
MaxGevity stands at the forefront of the canine wellness industry, distinguished by its commitment to enhancing pet health through innovation and advanced, scientfically formulated supplements and treats. The Company combines cutting-edge research with a passion for innovation to develop products that address critical health issues in dogs, aiming to set new benchmarks in pet nutrition and wellness. With a focus on innovation, quality, and efficacy, MaxGevity is poised for significant growth and continued impact in the global pet health market. To learn more, visit https://happytails-wellness.com.
About US Capital Global
Founded in 1998, US Capital Global offers a range of advanced financial solutions, including debt, equity, and investment products customized for middle-market enterprises and investors. The firm oversees direct investment funds while delivering comprehensive wealth management and investment banking services, encompassing M&A strategies and capital raising expertise. Among the notable entities within the consortium are US Capital Global Investment Management LLC, US Capital Global Wealth Management LLC, and US Capital Global Securities LLC, an SEC-registered broker-dealer and member of FINRA. To learn more, visit www.uscapital.com.
To learn more about US Capital Global or this engagement, email Lisa Terk, Senior Vice President, at lterk@uscapglobal.com or call +1 415–889–1026.
